• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson A G, Nowak A K, Opitz I, Scherpereel A, Reck M

机构信息

Royal Marsden Hospital NHS Foundation Trust, Section of Clinical Studies, Institute of Cancer Research, London, UK; National Centre for Mesothelioma Research, National Heart & Lung Institute, Imperial College London, London, UK.

Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.

DOI:10.1016/j.annonc.2021.11.005
PMID:34861373
Abstract
摘要

相似文献

1
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.
2
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v31-9. doi: 10.1093/annonc/mdv199. Epub 2015 Jul 28.
3
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.恶性胸膜间皮瘤：调查、诊断与治疗的最新进展
Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016.
4
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline Summary.恶性胸膜间皮瘤的治疗：美国临床肿瘤学会临床实践指南摘要
J Oncol Pract. 2018 Apr;14(4):256-264. doi: 10.1200/JOP.17.00012. Epub 2018 Mar 8.
5
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.恶性胸膜间皮瘤的治疗：美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 May 1;36(13):1343-1373. doi: 10.1200/JCO.2017.76.6394. Epub 2018 Jan 18.
6
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii43-4. doi: 10.1093/annonc/mdn083.
7
Diagnosis and treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤的诊断与治疗
Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.
8
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173.
9
Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.介绍新的英国胸科学会指南：胸膜恶性间皮瘤的调查与管理。
Thorax. 2018 Mar;73(3):210-212. doi: 10.1136/thoraxjnl-2017-211416.
10
Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.恶性胸膜间皮瘤：诊断、分期、陷阱与随访
Semin Ultrasound CT MR. 2017 Dec;38(6):559-570. doi: 10.1053/j.sult.2017.07.006. Epub 2017 Aug 2.

引用本文的文献

1
Sarcomatoid diffuse pleural mesothelioma in an 80-year-Old woman with long-term response to nivolumab plus ipilimumab: A case report.一名80岁女性患肉瘤样弥漫性胸膜间皮瘤，对纳武单抗加伊匹单抗有长期反应：病例报告
Respir Med Case Rep. 2025 Jun 26;56:102242. doi: 10.1016/j.rmcr.2025.102242. eCollection 2025.
2
Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series.纳武利尤单抗和伊匹木单抗在持久缓解后疾病进展的胸膜间皮瘤中的再治疗：病例系列
JTO Clin Res Rep. 2025 Apr 21;6(7):100835. doi: 10.1016/j.jtocrr.2025.100835. eCollection 2025 Jul.
3
Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma.
血浆和胸腔积液中的纤连蛋白-3作为间皮瘤的生物标志物
Radiol Oncol. 2025 Jun 16;59(2):225-232. doi: 10.2478/raon-2025-0024. eCollection 2025 Jun 1.
4
[Recent Advances in Medical Treatment of Malignant Pleural Mesothelioma].[恶性胸膜间皮瘤的医学治疗新进展]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):391-399. doi: 10.3779/j.issn.1009-3419.2025.102.18.
5
Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma.胸腔内热灌注化疗及辅助免疫治疗在胸膜间皮瘤治疗中的作用
Biomolecules. 2025 May 7;15(5):678. doi: 10.3390/biom15050678.
6
BAP1 Mutations and Pleural Mesothelioma: Genetic Insights, Clinical Implications, and Therapeutic Perspectives.BAP1突变与胸膜间皮瘤：遗传学见解、临床意义及治疗前景
Cancers (Basel). 2025 May 6;17(9):1581. doi: 10.3390/cancers17091581.
7
Unraveling BOLD-100 synergistic potential in pleural mesothelioma treatment: an in vitro study.揭示BOLD-100在胸膜间皮瘤治疗中的协同潜力：一项体外研究。
Invest New Drugs. 2025 May 8. doi: 10.1007/s10637-025-01540-9.
8
Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook.肿瘤电场（TTFields）疗法治疗不可切除的胸膜间皮瘤：疗效、安全性及未来展望概述
Curr Treat Options Oncol. 2025 May;26(5):398-414. doi: 10.1007/s11864-025-01320-w. Epub 2025 Apr 23.
9
The Role of Surgery in Pleural Mesothelioma: A Journey through the Evidence, MARS 2 and Beyond.手术在胸膜间皮瘤中的作用：循证之旅、MARS 2及其他。
Pulm Ther. 2025 Jun;11(2):117-127. doi: 10.1007/s41030-025-00295-1. Epub 2025 Apr 3.
10
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.全面的基因组和转录组分析为腹膜和胸膜间皮瘤的分子靶向治疗提供了选择。
ESMO Open. 2025 Apr;10(4):104532. doi: 10.1016/j.esmoop.2025.104532. Epub 2025 Apr 1.